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Introduction 
 
Research involving people who lack mental capacity, either as a result of a slow 
cognitive deterioration (as with conditions such as dementia), an acute event (such 
as a stroke), or never having had capacity to make complex decisions (such as 
those with profound learning disabilities), is vital if care for these groups is to be truly 
evidence-based. However, research involving groups considered to be vulnerable 
raises many ethical and legal issues: particularly with respect to informed consent for 
them to be included in a study (Harris and Dyson 2001; Shepherd et al. 2015; 
Sherratt et al. 2007; Sutton et al. 2003). The permissibility of proxy or surrogate 
decision-making for research involving vulnerable populations varies greatly between 
jurisdictions (De Martino et al. 2017; Veerus et al. 2013), however there is 
uncertainty whether proxies have sufficient moral authority to make such decisions 
(Wrigley 2007; Wrigley 2014), or if the ethical requirements can always be met 
(Sherratt et al. 2007). Proxy decision-making can be seen as comprising two main 
areas of ethical concern; the designation of the proxy who represents the person and 
why they are selected; and the nature of the decision-making itself. The ethical 
practice of proxy decision-making is an important issue, with substantial implications 
for the treatment and welfare of such individuals (Wrigley 2011). However, little is 
known about the ethical basis on which proxies act as decision-makers, or what 
factors are relevant in proxy decisions in practice, and there is a dearth of 
information or support available. Exploration and understanding of the ethical factors 
involved in these decisions, and interventions to inform and support those involved, 
are required in order for adults lacking capacity to have the opportunity to participate 
in research. 
  
The use of systematic reviews to address issues in medical ethics is relatively novel, 
covering diverse issues (Megone et al. 2016; McCullough et al. 2007; Strech et al. 
2008; Strech et al. 2013) and, although the practice has been widely debated, it has 
been suggested that they are a necessary development in the discipline (McDougall 
2013). This review examined the empirical ethical issues surrounding decisions 
made by proxies for adults lacking capacity, specifically regarding decisions made 
about research participation. The primary aim of the review was to bring together 
empirical evidence about ethical issues in the practice of proxy decision-making for 
research participation. The review provides a synthesis of the empirical data, and the 
development of a conceptual framework. 
 
Methods 
This review synthesised the empirical data from primary research derived from 
qualitative, quantitative or mixed-methods studies which examined relevant ethical 
issues. The review followed the framework synthesis approach outlined by Gough 
(Gough et al. 2012), based on five stages from familiarisation with the data, to 
identifying an initial conceptual framework, indexing data, through to mapping and 
interpretation of the data to iteratively refine and develop the conceptual framework. 
Ethical issues may have been clearly identified as such, or were ethical issues 
defined a priori from the literature - including proxy accuracy, burden, and comfort. 
An initial conceptual framework was developed utilising the review team’s existing 
knowledge and preliminary searches of the literature, which informed the search 
strategy and search terms. The review was prospectively registered on PROSPERO 
  
database of systematic reviews (CRD 42017054561). Ethical approval was not 
required for this review as no primary data were collected. 
Search methods 
A systematic search to identify relevant studies was performed following 
development of a search strategy with assistance from an information specialist, and 
piloting of appropriate search strategies. The search combined terms including: 
informed consent, research, proxy, surrogate, ethical principles, decision-making. 
The difficulties with identifying ethical issues using standard search filters have been 
noted elsewhere (Droste et al. 2010). Bibliographic databases were searched: Ovid 
MEDLINE, Ovid EMBASE, Ovid CINAHL, Ovid PsycInfo, ISI Web of Science, 
EUROETHICS and Scopus. Studies were limited to those in the English language, 
the search was not limited by date. Searches were conducted in January and 
February 2017. Supplementary searches were conducted including citation tracking, 
reference lists of included papers, and electronic table of contents (eTOC) of key 
journals for the last two years. The full search strategy is available in Appendix 1. 
Studies potentially eligible for inclusion were those reporting: 
 Empirical research, using qualitative and/or quantitative methods, aimed at 
understanding proxy consent to research participation for adults lacking 
decision-making capacity  
 Studies that report patients’ or researchers’ views/experiences of proxy 
consent/agreement for research participation 
 Ethical issues arising in obtaining proxy consent/agreement for research 
participation (which includes proxy accuracy, discrepancy, and comfort) 
  
Studies were excluded if they reported the views of clinicians, or did not include 
consent for research (such as treatment only), were protocol papers, or were not 
empirical research (such as argument-based normative papers). 
Study selection 
Titles and abstracts from the initial searches were screened based on the inclusion 
criteria by one researcher (NAME REMOVED FOR PEER REVIEW), and a sample 
of around 20 papers from the initial searches were reviewed by three researchers 
(NAMES REMOVED FOR PEER REVIEW) to ensure the accuracy of the application 
of inclusion and exclusion criteria. Full text of all potentially relevant studies were 
retrieved and screened using the same process (NAMES REMOVED FOR PEER 
REVIEW). Data from the included studies were independently extracted by two of 
the authors (NAMES REMOVED FOR PEER REVIEW) using a review-specific form 
developed following piloting on three heterogeneous papers. Quality assessment 
was conducted to assess the methodological rigour of included studies using 
standardised frameworks appropriate to the different types of study reviewed 
(Downes et al. 2016; CASP 2013). Studies were not excluded from the evidence 
synthesis based on quality assessment alone, as is increasingly the case for 
qualitative reviews (Carroll et al 2011). Quantitative studies were small with highly 
heterogeneous populations and measures. Meta-analysis was not feasible, therefore 
narrative summaries of the quantitative data were created. Data from the qualitative 
studies and narrative summaries were extracted and entered into NVivo 11. The 
number of studies reviewed and included/excluded are reported using Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (Moher et al. 
2009).  
  
Development from the preliminary conceptual framework to the final model 
Initial candidate themes were identified through a comprehensive review of the 
normative and empirical bioethical literature. A preliminary conceptual framework 
representing these themes was agreed by the review team during development of 
the study protocol. Data were coded thematically by one of the researchers (NAME 
REMOVED FOR PEER REVIEW) and coded data were reviewed by two additional 
researchers (NAMES REMOVED FOR PEER REVIEW). This review by two other 
researchers allowed the team to consider the validity of the coding and achieve 
consensus on the coded data. Adequacy of the initial themes (as opposed to codes) 
was assessed by three researchers (NAMES REMOVED FOR PEER REVIEW) after 
coding of data extracted from seven studies.  As themes and contexts expanded, 
and new themes emerged, the framework was developed, and data were coded 
iteratively. Definitions for each theme were developed and refined through 
discussions between the review team who agreed the inclusion of new themes.  
Data were mapped and aggregated under each theme. Proxy decision-making is 
highly complex and contextualised; therefore, attention was paid to the context 
surrounding each theme and individual study.  
Once the coding was completed, and adequacy of the final themes was confirmed, a 
revised conceptual framework was developed by the review team building on the 
earlier model. The revised framework, comprised of two dimensions, outlines the 
distinctive role and function of each theme and the complex relationships that exist 
between them.  The relative contribution of each study to the synthesis was 
summarised and tabulated under key themes of the framework.  
 
  
Results  
The search identified 1711 unique citations, of which 118 were assessed as meeting 
the inclusion criteria when the title and abstract were reviewed. Following review of 
the full text, 84 were excluded, with 34 studies remaining for inclusion in the review. 
 Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analysis 
(PRISMA) diagram 
Characteristics of the included studies are summarised in Appendix 2. The studies 
were published between 1986 and 2017. Almost all of the studies were conducted in 
North America (n=32). The majority of the studies involved research into conditions 
characterised by cognitive decline (dementia n=19, older people in long-term care 
n=2), followed by an acute event (critical care n=11, neurological emergencies n=2). 
No studies involved those whose disabilities may have resulted in never having had 
capacity to make complex decisions.  Only five of the included studies explored 
experiences of proxy decision-making in real-life situations, the majority examined 
  
hypothetical decisions. Sample sizes varied greatly between the studies, ranging 
from 10 to 1,515 participants. The studies generated both qualitative and quantitative 
data: research methods used in the studies were evenly divided between structured 
or semi-structured interviews and survey/questionnaire instruments, one study 
combined survey and interview methods, and one study combined survey and 
discussion group methods. Three studies evaluated interventions intended to 
improve proxies’ deliberation or decision-making processes. 
Key themes emerged (Appendix 3): four that relate to the ethical framing criteria of 
decision-making – 1) the use of a substituted judgement, 2) use of best interests, 3) 
a combination of substituted judgement and best interests, and 4) an alternative 
basis or ‘something else’; and four that can be considered to be active elements of 
proxy decision-making – 1) knowing the person, 2) relationship, 3) accuracy of the 
decision, and 4) balancing the risks, benefits and burdens, and attitudes towards 
proxy decision-making. The studies which generated data coded to each theme were 
tabulated (Appendix 4).  
Ethical framing criteria of proxy decision making 
Proxies’ decision-making was characterised by uncertainty, given the set of 
alternatives and possible consequences of each choice, both for the proxy and the 
patient. The proxy’s approach to decision-making emerged as a decision frame, 
which was dependent on their conception of the decision, potential outcomes, and 
consequences associated with a particular choice (Tversky and Kahneman 1981). 
Differences in the proxy’s formulation of the decision, and variables involved such as 
the perceived risks and benefits of the research, caused significant shifts in how the 
  
proxy was orientated to the decision, which provided a foundation for how the 
decision was made.  
Data on the framing intent of proxy decision-making was grouped into four domains: 
utilising substituted judgement, a best interests approach, a combination of both 
substituted judgement and best interests, and ‘something else’. These domains were 
identified from the questionnaires, survey items, and qualitative themes reported in 
the included studies, and map onto the proxy decision-making ‘standards’ described 
in the bioethics literature (Sugarman and Sulmasy 2010). In order to meet these 
standards, decision-making would need to fulfil certain criteria, such as decision-
making centring on maximising the well-being of the patient could be thought of as 
meeting the best interests standard, or basing it on the views and preferences would 
meet the substituted judgement standard. 
Six of the included 34 studies explicitly presented data on the framing criteria. 
Substituted judgement 
A substituted judgement was characterised by the proxy attempting to, or being 
directed to, make the decision that the person would themselves have made if they 
had capacity, as illustrated by this participant who had dementia: 
‘I would want her hopefully to make that decision on what she thought I would 
think. OK. Not what she thinks, not what somebody else thinks, but what I 
think…what she thinks I would have done’ (Black, Weschler, and Fogarty 2013, 
361).  
 
There were notably lower levels of support for the use of substituted judgement, in 
comparison to the use of best interests. 9% of proxies for people with dementia 
chose only substituted judgement as their preferred criterion of proxy decision-
making for research (Black, Weschler, and Fogarty 2013), 15% of patients with 
  
dementia preferred substituted judgement alone (Black, Weschler, and Fogarty 
2013), and 24% of proxies would base the decision on ‘what the patient would want’ 
(Karlawish et al. 2008). Despite this, when proxies were asked what criterion they 
had used for deciding about a proposed hypothetical study, around half stated they 
would decide primarily based on substituted judgment (Dunn et al. 2012). Proxies 
described using ‘substituted judgment’ in other decisions they made for the person 
(Dunn et al. 2012), although some were able to distinguish decisions about research 
from other types of decision, and reported that they used a different ethical criterion 
for different types of decision: 
‘for research I would make it based on what I thought she would want. If it was 
treatment, I would probably make it based on what I thought was best for her, but 
for research, I’d probably go with what I thought she would want’ (Black, 
Weschler, and Fogarty 2013, 361).  
 
Best interests approach 
A best interests approach focussed on what would maximise the person’s welfare or 
interests, as illustrated by this subject’s views: ‘what he thinks is best for me I would 
say. In that situation, I can’t want or not want’ (Black, Weschler, and Fogarty 2013, 
361). 
The use of only ‘best interests’ approach when deciding about research participation 
was supported by around half of proxies (Black, Weschler, and Fogarty 2013; Dunn 
et al. 2012) and a third of patients with dementia (Black, Weschler, and Fogarty 
2013, 361) in largely hypothetical scenarios. However, the majority of proxies for 
people with dementia answered that they would decide based on ‘what would 
maximise the patient’s well-being’ in a study involving actual research decisions 
(Karlawish et al. 2008). Proxies reported being accustomed to making everyday 
  
decisions using a ‘best interests’ approach (Dunn et al. 2012). They reported the use 
of a ‘best interests’ approach to research decisions, even where this might override 
what the person’s own decision might have been (Dunn et al. 2012), perhaps 
perceiving benefits from the research that justified overriding the person’s wishes in 
order to promote their well-being. Proxies clearly saw themselves as holding a 
protective role (De Vries et al. 2010; Muncie et al. 1997; Warren et al. 1986). Some 
proxies did not appear to distinguish between the interests of the person and those 
around them: 
‘Based on what would be best for him, not on what he would decide. I’ve made 
most of my decisions in life as to what would be best for him. What would be best 
for the family. There is no other way to decide (Black, Weschler, and Fogarty 
2013, 361).  
 
Use of a combination, or another criterion – ‘something else’ 
Moderate levels of support were given by proxies and patients for using a 
combination of substituted judgement and best interests for proxy decisions. 20% of 
proxies for people with dementia would use a combination of best interests and 
substituted judgement, and 18% of patients with dementia supported a combination 
of both criteria (Black, Weschler, and Fogarty 2013). Although some proxies 
conflated different framing criteria, reporting that they would use a combination, 
because that is what the person themselves would have used to decide: 
‘well the two might not be different. What’s best for me and what I would do might 
be the same thing and I think that’s what she would make the decision on. She 
would consider both’ (Black, Weschler, and Fogarty 2013, 361).  
 
In Dunn et al (Dunn et al. 2012), nearly half of the proxies agreed or strongly agreed 
with both, and spoke about the desire to incorporate both criteria in considering 
research participation. Most proxies in Karlawish’s study described a complex 
  
weighing process of their substituted judgement, with their preferences, and with the 
person’s own current preferences (Kalrawish et al. 2001). 
In Black et al (Black, Weschler, and Fogarty 2013), proxies and people with dementia 
were able to indicate that they supported another criterion - neither best interests nor 
substituted judgement but ‘something else’. 29% of proxies chose this third option, 
which often incorporated multiple concerns, such as considering whether it would be 
feasible for the person to co-operate with study procedures or to manage the 
travelling to study visits. The same proportion of people with dementia chose the 
‘something else’ option (29%), some wanting proxies to consider their own interests 
or those of family members, or following consultation with others (Black, Weschler, 
and Fogarty 2013). Proxies in Dunn et al explicitly described the need to weigh 
numerous factors concurrently, which would include the person’s preferences and 
personality before becoming ill, potential societal benefits, and current quality of life 
(Dunn et al. 2012). 
 
Active elements of proxy decision making 
Themes emerged from the data that were considered to be characteristics or 
elements of decision-making, that functioned to a greater or lesser extent in the 
decision-making process depending on the context, the relationship between the 
patient and their proxy, and the attitude of the proxy themselves. They actively 
directed proxies to accept or reject the option of research participation by serving as 
factors to be weighed in the decision-making process, as indicators to the proxy for 
how they should frame the decision, and sometimes as justifying reasons for the 
decision itself.  
  
Relationship between the patient and the proxy 
Participants reported that the choice of who acted as their proxy was important, and 
participants commonly used aspects of their relationships when they reported their 
views or experiences of proxy decision-making for research. The choice of proxy 
was reported as relevant to proxy decision-making in three studies (Berger et al. 
2005; Del Giudice et al. 2009; Sachs et al. 1994). One study that reported reasons 
for endorsing proxy consent centred on various aspects of trust, the closeness of 
their relationship and, in some cases, their previous experiences with decision-
making for them (Sachs et al 1994). Similarly, another study overwhelmingly cited 
trust and family closeness for reason for choosing the individual identified as their 
proxy, with love and closeness also mentioned, and many reporting that their trust 
was based on the proxy’s performance in a past crisis (Berger et al. 2005). The 
participants also generally saw no distinction between acting as a proxy for decisions 
about care or treatment and acting as a proxy for research, all participants presumed 
the same person would act as proxy for both types of decision (Berger et al. 2005). 
Notably, one study found there was low levels of support for a professional acting as 
their proxy, only 7% would allow a healthcare provider to provide consent on their 
behalf, compared to 88% who would allow a family member to provide consent (Del 
Giudice et al. 2009). 
Some participants discussed the reciprocal nature of family relationships that are 
built on mutual understanding and responsibilities. Older people in Berger et al’s 
study reported that they had chosen a family member to act as proxy on a mutual 
and relational basis: ‘She’s most familiar with what I want, as I am with what she 
wants. She’s really the one I trust the most’ (Berger et al. 2005). 
  
Two studies reported that proxies consulted other people to gain consensus before 
making a decision about research participation. Black et al included some proxies 
who had made actual decisions on behalf of a person with dementia, some of whom 
consulted with other family members before deciding (Black, Weschler, and Fogarty 
2013). Warren et al’s study with proxies for nursing home residents found that 60% 
of proxies consulted others before making a decision, of these about half (27% of the 
total) consulted medical professionals (Warren et al 1986). 
 
Accuracy of the ‘decision’ 
Much of the research focussed on whether proxies can accurately predict what the 
patient would decide about participating in a hypothetical research study (Bolcic-
Jankovic et al 2014; Bryant et al 2013; Ciroldi et al 2007; Coppolino and Ackerson 
2001; Muncie et al 1997; Newman et al 2012; Stocking et al 2006). These studies 
use the patient’s own prediction as the correct decision or the ‘gold standard’, 
against which the proxy’s decision or prediction is measured as a form of ‘diagnostic 
test’ (Coppolino and Ackerson 2001). In order to determine the accuracy of the 
proxy’s prediction or decision, the researchers have made the assumption that these 
are conceptually the same as the patient’s own decision. Proxies’ decisions that are 
incongruent with the patients’ own decisions are said to be either ‘false positive’ 
where the proxy would have enrolled the person when they would not have wanted 
to participate, or ‘false negative’ where the patient would have wanted to take part 
but the proxy declined to enrol them. 
Accuracy varied, with 76% reported in one study (Bryant et al. 2013). Similarly, in 
Ciroldi et al the patient-proxy discrepancy rate varied between 32% - 42% (Ciroldi et 
  
al 2007), and Newman et al found that the overall percentage of discrepancy 
increased as the perceived risk associated with the study rose (Newman et al. 2012). 
Stocking et al found that 49.7% of patient-proxy dyads directly disagreed about 
patient enrolment in at least one of the five hypothetical research projects described 
(Stocking et al. 2006). Of these disagreements, 47% involved the patient willing to 
enrol and the proxy was unwilling to enrol them, and 52.2% of disagreements 
reflected the reverse, proxy willingness and patient unwillingness (Stocking et al. 
2006). A study that examined the accuracy between patients who had been in critical 
care and their proxies, showed that most proxies would respond in accordance with 
patients’ wishes, although patients were more likely to agree to participation in the 
genetic research than their proxies would have allowed (Bolcic-Jankovic et al. 2014). 
Muncie et al found that the agreement between proxies’ decisions and the patients’ 
decisions was no higher than the decisions of randomly assigned, unrelated, proxies 
would be (Muncie et al. 1997). 
Confidence and certainty 
Three studies reported data relating to confidence in the proxy’s ability to decide in 
accordance with the person’s wishes or the certainty that the decision was in 
accordance with their wishes, all were studies which involved research in acute care 
settings. Bryant et al’s study with emergency department patients and their proxies 
found that both patients and proxies indicated relatively high degrees of confidence 
in the decisions they were making (Bryant et al. 2013). Confidence was associated 
with accuracy in a study with critical care patients and their proxies, which found that 
80% of proxies who were confident responded in agreement with patients’ wishes 
(Bolcic-Jankovic et al. 2014). Both proxies and patients showed overwhelming 
confidence in the proxy’s ability to make a decision based on the patient’s wishes: 
  
53.2% of proxies were very confident, 41.6% moderately confident, with only 5.2% 
not very or not at all confident (Bolcic-Jankovic et al. 2014). Patients also showed 
high levels of confidence in their proxy making a decision consistent with their 
wishes: 76.2% were very confident, 18.2% moderately confident, and only 5.1% not 
very or not at all confident (Bolcic-Jankovic et al. 2014). The only factor that 
influenced patients’ confidence in their proxies was whether they had prior 
discussions with them, however having a prior discussion was not significantly 
associated with proxies’ confidence in their own ability (Bolcic-Jankovic et al. 2014). 
Confidence was also associated with accuracy in Coppolino’s study with elective 
cardiac surgery patients and their proxies, which found that agreement was higher 
between patients and proxies where proxies felt “absolutely certain” or “certain” 
about their predictions (Coppolino and Ackerson 2001).  
Leeway given to proxy 
Eight out of the 34 included studies explored the amount of freedom or leeway the 
person would give their proxy when it comes to making decisions about research on 
their behalf. A majority of respondents were willing to give some or a complete 
amount of freedom or leeway to go against their currently stated preferences about 
future research participation, although it varied by scenario (Aayalon et al 2009; 
Karlawish et al 2009; Kim et al 2009; Kim et al 2013). Kim et al found that the leeway 
given to a close family member by caregivers for people with dementia varied little by 
study type, with 37% allowing no leeway, 57% some leeway, and 17% giving 
complete leeway (Kim et al. 2013). The main reasons given for granting leeway were 
that the proxies would have more or better information in the future, that the ratio of 
the risks/burdens vs. benefits may be different at the time of the study, or that the 
  
proxies may be able to better assess the risks at the time (Kim et al. 2013). Whereas 
those who would not give leeway perceived leeway as violating their right to make 
decisions for themselves (Kim et al. 2013).  
 
Knowing the person  
Five studies reported that knowing the person’s wishes and values were relevant 
factors in proxy decision-making for research (Berger et al 2008; Burns et al 2017; 
De Vries et al 2010; Dunn et al 2013; Overton et al 2013). Proxies described basing 
their decision-making as based primarily on their overall ‘knowledge’ of the person’s 
values, wishes, past behaviours and decisions, or some combination of these, by 
virtue of the relationship that exists between them (Dunn et al. 2012). Fidelity to the 
person’s wishes was achieved through representing their historical values, whether 
expressed in past conversations and behaviours, or embodied in patients’ character 
traits (Overton et al. 2013). Other proxies cited the need to ‘honour’ the person’s life, 
values, and wishes— even if they personally disagreed with the decision (Dunn et al. 
2012). However, in many cases, their explicit wishes were not known to proxies 
(Burns et al. 2017), and few proxies (30%) had previously discussed research 
preferences (Coppolino and Ackerson 2001).  
Many proxies felt that decisions about people with dementia taking part in research 
should be based on a written document expressing their willingness to participate 
that had been made before they lost decisional capacity (De Vries et al. 2010). One 
study found that 88% of participants stated that their family could agree for them to 
participate in research in the absence of a research advance directive, and 80% 
stated that their families could enrol them in research that may potentially benefit 
  
them even if their advance directive opposed enrolment in research (Wendler et al. 
2002).  
A commonly cited principle was altruism (De Vries et al 2010; Dunn et al 2011; 
Mehta et al 2012; Sachs et al 1994; Sugarman et al 2001), described as the desire 
to help research or to help others, to be a ‘good citizen’ (Sugarman et al. 2001), or 
the desire for future societal benefits (Dunn et al 2011). However, proxies were 
acutely aware of the moral difference between deciding for oneself and deciding for 
others based on altruistic motives (Dunn et al 2011). Altruistic motives were a joint 
motivation for the person and proxy (Dunn et al 2011), where proxies may have 
experienced altruism ‘by proxy’, although it was sometimes considered to be a 
secondary motivation, following the hope that the person themselves would benefit 
from the research (Sugarman et al. 2001). Some proxies were aware that their own 
children or grandchildren may someday develop the same disease (Alzheimer’s 
disease) and the trial might one day benefit them (Sugarman et al. 2001) – as a form 
of ‘selfish altruism’. 
In one study, proxies for people with dementia reported that using the person’s 
character as the basis of the decision was problematic, as the changes wrought by 
the disease made it impossible to use ‘who’ the person was in the past to make 
decisions today (De Vries et al. 2010). Proxies contrasted the personality and 
decision-making preferences of the person prior to developing dementia versus their 
view of the person’s current preferences (Dunn et al. 2012). Proxies had difficulties 
with the complex ethical issues, such as reconciling the need for research in order to 
develop new therapies, with their values relating to autonomy, experiencing and 
inflicting pain, and their responsibilities as carers (De Vries et al. 2010). Current 
preferences were frequently described by the proxies as taking precedence, 
  
regardless of prior preferences. Proxies believed that if the person currently would 
prefer not to participate, there was a certain point beyond which they would not be 
willing to ‘force them’ to participate (although the nature and extent of any such 
‘force’ was not reported) (Dunn et al. 2012).   
 
Balancing risks, benefits and burdens, and attitudes towards proxy decision-
making 
A number of studies addressed issues of perceived risks and benefits associated 
with participating in different type of studies, and study-related procedures that were 
considered burdensome. Dunn et al’s survey of community-dwelling people aged 
50+ found that study type was associated with willingness to participate, and to have 
a proxy to make decisions about research for them (Dunn et al. 2012). Participants 
were more likely to endorse a moderate benefit and minimal risk scenario, and less 
likely to endorse a minimal benefit and severe risk scenario, when compared to the 
minimal benefit and moderate risk scenario. Proxies for people with dementia 
commonly cited concerns about potential risks when interviewed (Dunn et al. 2011). 
In one of the few studies that involved a real-life decision about a research study the 
patient was actually being considered for (rather than merely hypothetical), if the 
proxies for critical care patients perceived that the risk of participation was too high, 
or felt patients may not benefit from participation, they did not contemplate further 
(Burns et al 2017). 
Comfort with proxy decision-making 
Four studies explored comfort with proxy decision-making on behalf of oneself or 
another person, or comfort with making decisions on others’ behalf. Dubois et al 
  
questioned five groups, including older people, informal caregivers, physicians, 
ethics board members, and researchers, using four scenarios (Dubois et al. 2011). 
They found that as the study’s risk benefit profile becomes less favourable, the 
proportion of participants expressing comfort with proxy consent decreased in all 
groups (Dubois et al. 2011). Where studies involved serious risks with greater 
potential benefits, their comfort with proxy consent was lower when the proxy was 
neither appointed nor designated, and higher when designated in a healthcare 
advance directive with instructions regarding research participation (Dubois et al. 
2011). 
Stocking et al examined patients’ own comfort with proxy decision-making for 
research for themselves, and found this also varied by study type (Stocking et al. 
2006). Patients with dementia were presented with five hypothetical studies, 32.9% 
said they would not be comfortable with proxy enrolment decision making in one or 
more of the hypothetical situations described, and their discomfort increased with the 
risk of the hypothetical study from 8.5% for a blood sample to 26.5% for intracranial 
stem cell implant (Stocking et al. 2006).   
Karlawish interviewed both patients with Alzheimer’s disease and their proxies and 
found high levels of comfort with proxy decision-making for research in both groups 
(Karlawish et al. 2008). 85% of proxies thought that proxy consent was appropriate 
in general and also for their relative if they were unable to provide their own informed 
consent (Karlawish et al. 2008). The proxies’ reasons included their role in making 
other decisions for the patient such as finances and treatment, and the patient’s 
wishes to contribute to research. 86% of patients showed similar consensus as their 
proxy. Reasons commonly cited were that the proxy had their best interest in mind, 
or knew of their intentions (Karlawish et al. 2008). 
  
Burden of proxy decision-making 
Six studies provided data on the burden of proxy decision-making for research. 
Proxies for people with dementia recognized that having the choice of whether or not 
to enrol the patient in research added to their burden. Proxies were acutely aware of 
the moral difference between deciding for oneself and deciding for others (De Vries 
et al. 2010). Studies with proxies in critical care found that the burden varied by 
study type or level of risk.  Barrett et al showed that few proxies reported it would be 
a burden to be involved in the consent process for the low risk (baseline) study or for 
the study involving two standard treatments (Barrett et al. 2012). However, a greater 
proportion felt it would be a burden to participate in decision making for the higher-
risk treatment and for the scenario where a decision was needed quickly (Barrett et 
al. 2012). Similarly, Mehta et al reported that 20% of proxies found the process very 
burdensome in the higher risk and shorter enrolment window scenarios, and up to 
30% were very uncomfortable making the decision (Mehta et al. 2012).  
Similarly, the perceived risk also affected the burden experienced by proxies for 
people with dementia (Sugarman et al. 2001). Burden could be decreased if the 
patient themselves was able to play a meaningful role in the decision, however some 
reported that, even when the person could be involved in the decision, the burden 
was high because the decision to participate meant acknowledging the dementia:  
‘Well, it felt like . . . you was saying [sic] that you knew that he wasn’t going to be 
capable of making his own decisions. You know that it hurts to know . . . that he’s 
getting to that point that he can’t even make decisions for himself.’ (Sugarman et 
al 2001, 1115). 
 
  
One study reported that burden may be experienced as a result of feeling that other 
family members would not agree with their decision or would ‘blame them’ for 
enrolling the person (Burns et al. 2012). 
Acceptability of proxy decision-making for research 
Seven of the included studies examined acceptability of proxy decision-making, 
either from a societal perspective, for themselves at some future point, or as proxies 
on behalf of another person. A survey of 1469 community-dwelling people aged 50+ 
in the US showed high levels of support, with 70.7% agreeing to have proxy-
informed consent for themselves (Aayalon et al. 2009). A study with 240 people who 
had survived a critical illness reported that, compared to alternative consent models, 
most patients (76%) selected ‘‘consent by surrogate decision-maker prior to 
enrolment’’ as their preferred framework, regardless of the level of study risk (Scales 
et al. 2009). In Sachs et al’s study with different populations, those considered the 
‘well elderly’ group reported a variation depending on the perceived risk of the study, 
with willingness to accept proxy consent declining from the blood sample study, to 
brain autopsy, to medication trial, to surgery/medication study (Sachs et al. 1994). 
Comments about proxy consent from this group were very similar to those of the 
people with dementia, one participant who would refuse to allow a proxy to decide 
about the surgery/medication protocol said: “It’s too dangerous for someone else to 
decide” (Sachs et al. 1994, 408) 
Overwhelmingly, proxies reported that they are keen to be involved. The majority (90 
%) of proxies for critical care patients wanted to be involved in decision making 
about research on their behalf (Barrett et al. 2012). Although, acceptability of 
involvement in the consent process was less in the higher risk studies and those 
  
mandating less time to make a consent decision. Similarly, Kim found that 92-94% of 
proxies for dementia patients supported proxy consent for the less invasive study, 
compared to 53% - 62% for the most invasive of the hypothetical research studies 
(Kim et al. 2010). An earlier study led by Kim found that risk also influenced the older 
people they surveyed (Kim et al. 2005). They found that acceptability of proxy 
consent-based research was strongly influenced by the level of perceived risk, 
resulting in an adjusted odds of finding a minimal risk study acceptable for proxy 
consent 60 times relative to that for high risk studies (Kim et al. 2005). However, in 
their 2009 study Kim et al found most of the 1515 community dwelling aged 50+ 
were supportive of allowing families to make proxy consent decisions for dementia 
research (67.5% to 82.5% by study type), even for a first-in-man gene transfer study 
nearly 68% stated that society should allow families to make such proxy decisions 
(Kim et al. 2009). 
Most (96%) community-dwelling older people were willing to designate a proxy for 
research decision making (Karlawish et al. 2009). 
Willingness to participate 
Seven studies explored participants’ willingness to take part in research should they 
lose capacity. Kim et al found that, generally, older people’s levels of acceptability for 
proxy consent for themselves were comparable to their willingness to participate in a 
research study, although for one hypothetical study (a vaccine study) a significantly 
greater proportion would allow proxy consent than would themselves want to 
participate (Kim et al. 2009). Patients in emergency departments and other members 
of the public reported a willingness to participate in a hypothetical SAH trial, with 
34% definitely participate, 20% probably participate, 22% possibly participate, 5% 
  
probably not, and 10% would definitely not participate (9% could not decide) (Del 
Giudice et al. 2009). 
The vast majority of participants in Wendler et al were willing to participate in clinical 
research if they lost the ability to consent, ranging from 80% - 99% depending on 
study type and perceived level of risk or benefits (Wendler et al. 2002). Exploratory 
analyses found no significant associations with characteristics such as sex, age, 
religion, and previous execution of a healthcare advance directive. Critical care 
patients were significantly less likely to participate in research as the perceived risk 
associated increased, with no associations found between their length of stay in 
critical care, age, race, or gender (Newman et al. 2012). Similarly, older people 
interviewed in Berger et al were reluctant to consider research involving taking 
experimental drugs or those with serious known side-effects (Berger et al. 2008). 
Proxies’ willingness to participate in research themselves was associated with their 
willingness to enrol the patient as their proxy decision-maker. Clarridge found that 
the likelihood of the proxy for a critical care patient participating in research 
influenced the likelihood of that proxy permitting the patient to participate in research 
(Clarridge et al. 2015). Muncie found that proxies’ decisions for their own 
participation were significantly associated with their ‘guesses’ of the patient’s 
decision, and therefore with their decisions for the patient (Muncie et al. 1997). 
Consequently, for each hypothetical study, the proxies’ decisions for the patient were 
significantly more frequently in agreement with the proxies’ own decisions for 
themselves than with the patients’ decisions to participate. Similarly, 80% of proxies 
for nursing home residents would be willing to participate in the hypothetical study, 
and proxies who would take part themselves were significantly more likely to give 
consent for the care home resident they represented (Warren et al. 1986). 
  
Three studies found that proxies were more likely to enrol themselves, than would be 
willing to agree for the other person to take part. Both Sachs et al (Sachs et al. 1994) 
and Kim et al (Kim et al. 2013) found that proxies as a whole were more willing to 
participate themselves than they were willing to give proxy consent for their relative, 
regardless of study type. Lim found that this varied by study type, with proxies being 
five times more likely to have a favourable opinion for themselves as the patient in 
the lower risk studies, and six times more likely for the higher risk study (Lim et al. 
2013). 
 
Discussion 
This systematic review suggests that proxy decision-making for research can be 
thought of as being comprised of two dimensions; the framing criteria used by the 
proxy to make a decision, and the active elements that feature in the decision-
making process itself. The relationships between the framing criteria and the active 
elements are complex, operating on a number of different levels, as components 
interacting between themselves, with both explicit and implicit modes of interaction, 
and which may be context dependent. The conceptual framework provides a 
synthesis of the concepts and perspectives that emerged from the empirical data, to 
describe the relationships between the framing criteria used by the proxy, and the 
active elements of decision-making (Figure 2 Conceptual framework).  
Figure 2. Conceptual framework 
 
  
The ethical framing criteria (Figure 2, A) play a structural role which forms the basis, 
or orientation, from which the proxy engages in decision-making, and shapes the 
nature of the decision. The decision frame used by the proxy was dependent on their 
formulation of the decision, the potential outcomes, and consequences. It directed 
the proxy’s perspective on decision-making – whether they attempted to determine 
what the person’s decision would have been through ‘standing in their shoes’ to 
meet the criteria of a substituted judgement, or whether they provided their own 
determination of what would derive the maximum benefit for the person and would 
therefore be in their best interests. Where proxies reported the use of a combination 
of both criteria, it was either expressed as hope that the decision they made would 
match the outcome of both, or that if they made a substituted judgement it wouldn’t 
be against the person’s best interests. However, the low levels of support for both 
substituted judgement and best interests - substituted judgement in particular - and 
support for a combination of both or for a ‘something else’ option may reflect the 
complexity of proxy decisions in practice. This complexity was described as a 
complex weighing process of the proxy’s substituted judgement, with their own 
preferences, and with the person’s current preferences (Karlawish et al. 2001). In 
  
contrast to the rigid tripartite bioethical hierarchy of proxy decision-making standards 
(known wishes, substituted judgement and best interests), described as having 
become ‘canonical’ in the bioethics texts and professional codes (Sugarman and 
Sulmasy 2010), a picture emerges from the data of complex multifaceted decisions 
that often involve a weighing up of numerous factors. As one participant noted, in 
real life it is not a ‘narrow framework’ (Black et al. 2013).  
Interplay between the dimensions of framing criteria and active elements 
The four active elements (Figure 2, B) influence how proxy decisions are made by 
modifying the framing criteria used by the proxy, and in turn, how or when the 
elements are drawn upon is influenced by the criteria used. Active elements had a 
varying functional role. They were persistently involved as factors considered by the 
proxy, as indicators to the proxy for how they should frame the decision, and 
sometimes as justification for the decision itself, it varied by context, patient-proxy 
relationship, and the attitude of the proxy themselves.  
Associations also exist between a number of elements. The nature of the 
relationship between the person and their proxy is one such element that operates in 
both substituted judgement and best interests approaches, and is also linked to the 
‘knowing the person’ element. The relationship provides the proxy’s authority to 
make decisions on behalf of adults lacking capacity (Buchanan and Brock 1989) by 
enabling them to provide a substituted judgement, but the relationship can also 
enable to the proxy to be best placed to determine what is in the best interests of the 
person. The closeness of the relationship is the mechanism by which the proxy 
knows the person’s wishes and preferences, and is also the reason they are chosen 
by the person to represent them as proxy (Berger et al. 2005; Sachs et al. 1994).  
  
By contrast, the accuracy element appears to only be relevant when substituted 
judgement is utilised by the proxy where, unlike in best interest approaches, there 
could be considered a ‘correct answer’ to match. Studies which explored the 
accuracy of a proxy’s substituted judgement generally demonstrated moderate levels 
of accuracy or agreement between patients and their proxies. As a result, some 
authors noted that the variable predictive accuracy of proxy decision-makers raised 
questions about the ethics and validity of proxy decision-making (Bryant et al. 2013; 
Coppolino and Ackerson 2001), which threatened the ethical principle of autonomy 
for the patient (Newman et al. 2012).  However, such studies have important 
limitations and methodological flaws (Johansson et al. 2008), including that these 
studies are based on the assumption that there is similarity in decision-making 
patterns in hypothetical and actual treatment situations (Kohn 2015). Despite the use 
of the patient’s own ‘decision’ as the gold standard, the patient is merely expressing 
a prediction (a preference or disposition (Egonsson 2010) rather than a consent 
decision, and in reality, proxies are being required to ‘match a guess’.  
Individuals also reported granting leeway or a margin of flexibility to their proxy, even 
when an advanced directive was in place. This appears to reflect their understanding 
that these are future decisions, which means that factors and information will be 
involved that are not currently known, and therefore the decision outcome cannot be 
pre-determined. Leeway appears to be influenced by perceived risks and benefits. 
Factors such as leeway and knowledge of relevant advance directives may also be 
part of ‘knowing the person’ that a proxy would incorporate into their substituted 
judgement. Knowledge of the person’s altruistic tendencies may function in a similar 
role, but may also be affected by the proxy’s own altruism, linked to selfish reasons 
or otherwise (Dawkins 2006). 
  
One element - the risks and benefits of participating and the nature and invasiveness 
of the study procedures - was identified as a characteristic that operated to influence 
proxy decision-making in a number of different roles. It determined whether a 
substituted judgement or best interest determination was made by proxies, where if 
the burden was considered to be high then a substituted judgement was rejected, 
and best interests was used by some proxies (Burns et al. 2017) although not by all 
(Dunn et al. 2013). It also served as a justifying reason for the decision itself, where 
it was the ‘right’ decision if the person could gain benefit from participating (Aayalon 
et al. 2009).  
The attitudes of the proxy towards research involving people without capacity, and in 
particular their willingness to participate in research themselves also operated at a 
number of levels and directions. The studies reported moderate to high levels of 
support for involving people who lack capacity in research, and acceptability of proxy 
consent models, although this too appeared to vary by perception of study risk and 
invasiveness of study procedures. Proxies who were willing to participate themselves 
were sometimes more likely to enrol the other person in two critical care studies 
(Clarridge et al. 2015; Lim et al. 2015), although this was not observed in other 
studies in dementia (Sachs et al. 1994; Kim et al. 2013) which supports the 
contextualised nature of decision-making. Proxies’ decisions for the others generally 
reflected what they would want done for themselves, suggesting that rather than the 
proxy ‘standing in the shoes’ of the patient, the proxy decides as though the patient 
were in their (the proxy’s) own shoes (Muncie et al. 1997). This may be because, 
when faced with uncertainty about what to decide when a person’s wishes were not 
clear, the proxies considered themselves to be ‘the reasonable person’, and 
  
therefore decisions they would make for themselves should be applicable to the 
other person (Muncie et al. 1997). 
 
Gaps in the empirical evidence  
The review identified important gaps in the empirical literature. The included studies 
were predominantly conducted in North America, for example no studies from the 
UK, or Africa were found, only one from Europe and Asia respectively. None of the 
included studies involved people who had experienced head injury, mental illness, or 
those requiring palliative care, which make up a proportion of the population with 
impaired capacity. Additionally, proxies for individuals who have never possessed 
decision-making capacity, such as people with profound intellectual or 
developmental disabilities, were not included in any of the studies. Many of the 
studies involved hypothetical scenarios, and in some studies participants had little or 
no experience of making actual decisions about research or proxy decision-making. 
This may affect the generalisability of the findings from the included studies.  
No studies reported the experiences of researchers or health or social care 
professionals acting as proxy decisions-maker by virtue of their professional role 
where no personal proxy was available – although this may reflect the legal position 
in the jurisdictions the studies were conducted in. The study which included data on 
support for, or comfort with, professional or clinician involvement in decision-making 
showed low levels of support for professional decision-makers (Del Giudice et al. 
2009), although this is authorised in a number of jurisdictions (De Martino et al. 
2017, Mental Capacity Act 2005, Medicines for Human Use (Clinical Trials) 
Regulations 2004). 
  
 
Strengths and limitations 
This is the first study to systematically review data from empirical studies exploring 
proxy decision-making for research. Pragmatic search strategies were used in order 
to include a wide range of populations and methodologies to provide a rich and 
contextualised account. A framework synthesis approach has enabled a novel 
conceptual framework to be developed which is informed by the empirical data, and 
addresses the complexity of proxy decision-making. 
The shortcomings of empirical research in medical ethics have been debated, 
including that a lack of normative analysis means that the empirical studies remain 
on a descriptive level (Salloch et al. 2012). Attempting to draw (meaningful) 
normative conclusions from empirical studies has been widely criticised (Ives, Dunn 
and Cribb 2017, 5). Normative analysis of the findings from this review are 
considered to be beyond the scope of this paper, however this paper does enable a 
broad view of the empirical literature in a form which is suitable for further normative 
analysis. 
Limitations of the studies reviewed include that the difficulty with search filters’ 
sensitivity and specificity in identifying ‘ethical’ issues may have resulted in relevant 
studies not being included in the review. The restricted populations and settings of 
the included studies may limit the transferability of the studies to other populations 
and jurisdictions. Patients who were included were, necessarily, those with less 
severe dementia, or survivors of critical illnesses who had regained decision-making 
capacity.  
  
Extracted data were not coded independently as this review used an interpretive, 
iterative approach and we were therefore not coding data for reliability. The review 
team established the validity of coding through discussion and achieving consensus 
between three researchers during the iterative coding process. 
Methodological flaws limit the generalisability of some studies that explored the 
accuracy of proxy predictions, and caution must be used when interpreting the 
findings and drawing conclusions about the ethical validity of proxy decision-making 
as a result. The complexity of proxy decision-making for research, and the myriad of 
ethical issues involved, are problematic to research using empirical methods. 
Quantitative methods using survey and questionnaire tools do not sufficiently capture 
the depth of the proxy experience, nor the views of patients and members of the 
public.  
Studies that explored the framing criteria for decision-making commonly asked 
proxies and patients to state whether they supported, or used, a substituted 
judgement or a best interests approach, or both. These terms were not necessarily 
explained to participants, nor did authors interpret participants’ responses 
consistently, and studies may have been affected by participants providing socially 
acceptable responses. 
 
Conclusions 
This review has sought to systematically review the empirical research on proxy 
decision-making for research involving adults who lack capacity, using a framework 
synthesis approach. Decision-making on behalf of a person who lacks capacity is 
  
complex, ethically challenging, and highly contextualised and multifactorial in nature. 
The uncertainty about how decisions ought to be made by proxies, the weight of 
making a decision on behalf of another person, whilst balancing any potential risks or 
benefits, is burdensome for proxies.  
The accounts of proxy decision-making given in normative ethical literature (and 
required by ethical frameworks) are not clearly or unequivocally supported by the 
empirical data on decision-making in practice, nor do they definitively reflect the 
views and preferences of those who are likely to require proxy decision-making. The 
findings from this review challenge the accepted reductive approach to proxy 
decision-making. It emphasises the differences between the standard interpretation 
of substituted judgement where the proxy is required to replicate the decision the 
person would have made, if they had capacity to do so, which studies using the ‘gold 
standard and diagnostic test for accuracy’ attempt to test empirically, and the 
reported experiences of proxies. Proxies tell a story of balancing a number of factors 
during the decision-making process, which seeks to honour the person’s wishes 
while assessing the risks and benefits for the patient.  
The studies suggest that the relationship between the patient and the proxy has a 
fundamental role. The relationship is the justifying reason for being chosen or acting 
as a proxy, it provides the proxy’s authority to act on the person’s behalf, and 
influences the factors incorporated into the decision-making process through their 
knowledge of the person.  
The empirically informed framework for proxy decision-making for research proposed 
here represents an initial attempt to take account of the contextual use of substituted 
judgement and best interests approaches, and the balancing of the active elements 
  
in the decision-making identified in this systematic review. This review indicates that 
this may more accurately reflect both decision-making in practice as reported by 
participants in the studies reviewed, and the reasons for having someone who knows 
the person well act as their proxy. Further work to describe and develop the 
framework, together with empirically testing the framework with those involved in 
proxy decisions about research participation, may be more helpful than seeking 
ways to improve proxies’ ability to ‘match a guess’ in a world of counterfactual 
wishes and hypothetical scenarios.  
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Appendix 1 Search strategy 
 
Initial searches were developed in December 2016 using MEDLINE. A literature 
review of the analytical/philosophical literature helped to develop the initial conceptual 
framework and inform the initial search strategy. Subsequent searches were 
developed with attention to the conceptual framework and terms used in the literature. 
Final searches were conducted in January and February 2017.  
 
Electronic resources  Ovid MEDLINE <1946 to January Week 3 2017>   EMBASE <1996- 2017 January 03>  PsychINFO <1806 – present>   CINAHL plus with full text <1986-present>  BNI <1985-present>  SCOPUS <1966-present>  Web of Science <1900-present>  EUROETHICS 
 
Studies were limited to those in the English language, the search was not limited by 
date. Supplementary searches were conducted including citation tracking, reference 
lists of included papers, and electronic table of contents (eTOC) of key journals for the 
last two years. 
 
Example search strategy 
Ovid MEDLINE <1946 to January Week 3 2017> 
1. exp Proxy/ 
2. proxies.tw. 
3. exp Informed Consent/ 
4. exp Third-Party Consent/ 
5. (consent adj3 (informed or proxy or proxies or surrogate*)).tw. 
6. (proxy* adj3 (consent or choice* or decision* or decide or choose or prefer or 
permission or view*)).tw. 
7. (proxies adj3 (consent or choice* or decision* or decide or choose or prefer or 
permission or view*)).tw. 
8. (surrogate* adj3 (consent or choice* or decision* or decide or choose or prefer 
or permission or view* or preference*)).tw. 
9. (informed consent adj3 (proxy or proxies or surrogate*)).tw. 
10. (substitute* adj3 (consent or choice* or decision* or decide or choose or 
prefer or permission or view)).tw. 
11. (principle* adj2 ethic*).tw. 
  
12. (accuracy adj4 (proxy or proxies or surrogate* or decision)).tw. 
13. substituted judgement*.tw. 
14. best interest*.tw. 
15. comfort.tw. 
16. (trial* or study or studies or research).tw. 
17. (empirical* adj3 (study or studies)).tw. 
18. (philosoph* adj3 (study or studies)).tw. 
19. exp "Surveys and Questionnaires"/ 
20. (("semi-structured" or semistructured or unstructured or informal or "in-depth" 
or indepth or "face-to-face" or structured or guide) adj3 (interview* or 
discussion* or questionnaire*)).ti,ab. 
21. or/11-15 
22. or/16-20 
23. or/1-10 
24. 21 and 22 and 23 
 
 
 
 
